Pharma v. Pharma
... otherwise exist are extended for a further 6 months. – ANDA moratorium: No ANDA can be filed during the 4-year period after the NDA approval for an NCE drug. – Linkage stay: If a patent challenge is made in an ANDA and a lawsuit filed within 45 days, the ANDA approval is stayed for up 30 months if n ...
... otherwise exist are extended for a further 6 months. – ANDA moratorium: No ANDA can be filed during the 4-year period after the NDA approval for an NCE drug. – Linkage stay: If a patent challenge is made in an ANDA and a lawsuit filed within 45 days, the ANDA approval is stayed for up 30 months if n ...
PowerPoint
... IPR and the abuse of market dominant position To examine whether a conduct concerning IPR is the abuse of market dominant position, the Antitrust Law Enforcement Agency should analyze the constitutive requirements of the abuse of market dominant position in accordance with Article 17 of Antitrust ...
... IPR and the abuse of market dominant position To examine whether a conduct concerning IPR is the abuse of market dominant position, the Antitrust Law Enforcement Agency should analyze the constitutive requirements of the abuse of market dominant position in accordance with Article 17 of Antitrust ...